January 31, 2025

Sixth pharmaceutical plant of the Pharmasintez group of companies will be built in the "Technopolis Moscow" special economic zone.

Pharma

The Pharmasintez Group of Companies has announced receiving the status of a resident of the Special Economic Zone (SEZ) "Technopolis Moscow." The SEZ resident status opens up new opportunities for development and strengthening positions in the pharmaceutical industry market, providing a range of benefits, including access to modern technological platforms and state support in infrastructure and production development.

Oleg Astafurov, Vice President for Government Relations at Pharmasintez Group, and Timofey Batalov, Production Director at Pharmasintez-Biocapital, presented the business project of the Pharmasintez Group of Companies at the ceremony for becoming residents of the SEZ "Technopolis Moscow." The investment project for creating a production facility for import-substituting oncological drugs at the "Alabushkino" site (Zelenograd, Moscow) will be implemented as part of the fulfillment by JSC "Pharmasintez" of the conditions of an offset contract with the Moscow Department of Health. According to this contract, the first deliveries of medicines for the needs of the Moscow healthcare system are expected to begin as early as the beginning of 2026.

"The Pharmasintez pharmaceutical group of companies, being one of the flagships of the domestic pharmaceutical industry and primarily specializing in the production of socially significant medicines for the needs of medical and preventive institutions in the country, will build and launch one of its new plants in 2025. By order from the Government of Moscow, the sixth pharmaceutical plant will be built on the 'Alabushkino' site of the SEZ 'Technopolis Moscow.' The new production facility will specialize in the manufacture of oncological drugs, which will strengthen the group's position in the oncology segment, where every third package for treating oncological diseases is already produced at Pharmasintez plants. This is our first joint project with the Government of Moscow, and our plans for the future include deepening and expanding cooperation in ensuring the Moscow healthcare system with effective and safe medicines, including innovative ones," noted Oleg Astafurov.

 

Source: FARM-PROM

Latest posts by email:
To subscribe to the newsletter, first Come in Either Register

Other news

Pharma

In today’s world, effective resource management is becoming an increasingly crucial aspect of successful business operations. This is especially true for industries where equipment plays a key role—such as pharmaceuticals, cosmetology, and the food industry.

02.10.2025
Pharma

A new administrative and production-warehouse complex of the pharmaceutical enterprise Farmstandart-UfaVITA has been commissioned in the center of Ufa. Investment exceeded 10 billion rubles, and new production lines are designed to produce 75 million medicine packages per year.

06.10.2026
Pharma

A Russian drugmaker, with the support of integrator IST-PAK, deployed an Italian SIEMPHARMA SRL counting-filling line for packaging tablets and capsules into plastic jars. The project was delivered despite a constrained shop floor and a fixed budget.

02.10.2026
Pharma

Farmasyntez Group commissioned a new pharmaceutical enterprise in Ussuriysk (Primorsky Krai). The plant with a design capacity of 12 million medicine packages a year was implemented under the import substitution program Pharma-2030; 90% of manufactured items are on the VED list.

01.10.2026
Pharma

Argumentum Pharma is completing the equipping of its new pharmaceutical plant in Moscow region's Dubna SEZ: high-tech automated filling and packaging lines have already been installed. Total investment in the project is estimated at 2.5 billion rubles, with commissioning planned before the end of 2026.

29.09.2026
Pharma

The Russian pharmaceutical manufacturer PFK "Renewal", operating under the Renewal brand, has commissioned a new production facility for the production of vital and essential medicines (VED) in the Novosibirsk region. The area of the complex exceeds 18.1 thousand square meters, and the design capacity reaches 100 million packages of finished products annually.

23.09.2026
Pharma

"VERTEX" is completing the commissioning of a blister-cardboard line with double-sided aluminum packaging, unique for its capacities. The new machine will become the tenth blister line of the enterprise and will allow to produce about 260 thousand packages by the end of 2026.

21.09.2026
Pharma

""""On Moscow Industry Day, Sergei Sobyanin opened a new production complex "Generium-Next" (GC "Farmstandart") at the Alabushevo site. The company will produce genetically engineered drugs for orphan and socially significant diseases for 8.5 billion rubles.

18.09.2026
Pharma

""PSK Pharma" company has completed a major project to modernize the production site of capsules with powder for inhalation at its own enterprise in the "Dubna" special economic zone. Investments exceeded 1 billion rubles, which made it possible to double the capacity of the line — from 80 to 160 thousand capsules per hour — and purchase new analytical and tablet equipment.

17.09.2026
Pharma

PJSC "Biosynthesis", one of the largest pharmaceutical enterprises in the Penza region, is preparing to launch a reconstructed production site for tablet dosage forms. The volume of investments in the project is 350 million rubles, and the implementation will increase the production of drugs, including those included in the list of VED.

16.09.2026
Pharma

Pharmaceutical manufacturer "Nizhpharm" announced the launch of a new line of packaging and packaging of soft dosage forms. The volume of investments in the project amounted to 158 million rubles, the maximum speed of the equipment reaches 270 packages per minute, which will increase production by 50%.

15.09.2026
Pharma

Gerresheimer, a German company specializing in glass, specialty glass, and plastic packaging for the pharmaceutical, cosmetic, and food industries, announced the commissioning of a new plant in Zhenjiang, China.

27.07.2026